ENDOMETRIOSIS MEDICAL RESEARCH TRIAL
The purpose of this study is to look at the safety and effectiveness of Elagolix 150 mg when taken
together with a combined oral contraceptive (COC) that contains an estrogen and a progesterone, in premenopausal women with endometriosis pain.
You may be eligible to take part in the study if you:
Ages 18 to 49 years of age experiencing endometriosis pain
Have documentation of a surgical diagnosis for Endometriosis
Willing to utilize non-hormonal birth control and contraceptives
You may be compensated for time and travel, up to $2000 for your time and participation.
Contact us today to learn more about our current study opportunity. Signup online by completing the contact form below, or email our Patient Recruitment Specialist, Autumn Wofford, firstname.lastname@example.org. You can call us toll free at 803.764.2406.